Are DIR fees and clawbacks slowing your growth?
Download the DIR Fees Fact Sheet now.
DIRECT AND INDIRECT REMUNERATION FEES
PDS is committed to assisting our members with a better understanding of DIR fees and how to improve processes to combat these fees.
Direct and Indirect Renumeration fees, or DIR fees, represent a variety of fees imposed on pharmacies that participate in Medicare Part D. In the past few years, many PBMs have added a performance component into their contracts, in which the amount of DIR fees assessed to the pharmacy is impacted by clinical performance. These performance-based DIR programs have evolved and expanded over the years. However, each plan evaluates performance, and thus calculates their DIR fees differently.
With PDS, you’ll have the exact tools and resources you need to mitigate DIR fees and improve your bottom line.
One of the ways that PDS is committed to your success is by providing you with a team of experts who can help you implement strategies to outplay the PBMs and reduce the impact DIR fees have on your business.
You’ll be assigned a dedicated Performance Specialist who will be there for you and lead you through growing programs that will increase your quality patient outcomes and adherence, such as synchronization programs and therapeutic optimization.
You’ll have access to the exclusive PDS member portal, PDSadvantage, where you’ll find a library of tools to help as you implement.
You’ll collaborate and engage with a community of 1,200+ PDS member pharmacies who are implementing adherence and growth programs to fight DIR fees and raise their EQuIPP scores alongside you.
You’ll be assigned an expert business coach who will help you achieve your business goals and make you feel at ease.
Download the PDS DIR Fees Fact Sheet now.
Over a 4-month period, a multi-store PDS member saved over $14,000 in DIR fees for one payer.
A group of 11 pharmacies (different owners & regions) saved over $115,000 in fees year-over-year as a result of improving performance scores.
Two high-performing pharmacies decreased fees by 56% ($42K) and 76% ($22K), year over year.
MEMBER SUCCESS
“The monthly DIR and Outcomes scorecards we get from PDS help us see what we are doing right and what needs to be worked on to improve our performance scores. Within one month of our teams working with PDS one store was able to increase their statin performance score by over 18%. Through the monthly engagements with PDS, we have seen increased performance scores and increased profit margins.”
Foster Corner Drug Group
Perry, OK
Foster Corner Drug Group in Perry, Oklahoma faced the same challenge that many independent pharmacies do. Fees and clawbacks were significantly impeding on their profits.
PDS worked with the pharmacy team to put a plan in place to mitigate DIR fees. Step one was education. With six pharmacies in the group, it was critical that they took the time to educate their teams on DIR mitigation strategies and utilizing EQuIPP and OutcomesMTM.
Every month PDS met with all members of the clinical team to discuss processes and outcomes related to their goal: improving performance and mitigating DIR fees.
Each pharmacy receives an EQuIPP report card with the latest YTD plan-level performance on adherence measures for the major plans. This allows all teams to easily identify where they are performing well, what needs improvement, and recommended action steps.
In just four months all 6 locations showed improvement in their overall CMR (comprehensive medication review) completion rate, which directly impacts DIR fees for some payers. Some locations in the group have more than doubled their rate and one location has consistently been achieving a 100% CMR completion rate for both plans they participate in.
Quality measure performance is another area that the group has seen significant improvements. They earned 29.4% of an available performance payout for a large pay-for-performance program in 2020, up from 17.6% in the prior year. One location (Foster Corner Drug) showed improvement of 23% for their statin management measure score in just 2 months and adherence scores increased by an average of 4.8% in the same time period.
This pharmacy group has shown what an engaged, educated team can achieve. DIR fee mitigation has proven to be very successful, and the pharmacies are excited to see continued success.
Keep the money you earn IN your pharmacy with PDS.
COVID CARE OPTIMIZATION PROGRAM
DIR FEE
MITIGATION
NON-PBM REVENUE OPPORTUNITIES
CASH FLOW
CHALLENGES